Home/ Supplements/ Niacin/ Cholesta-Lo

Cholesta-Lo

product on market Tablet or Pill Bronson Safety: 97/100
97/100

This product looks safe

  • Niacin: 66.67mg is 1.9× the Tolerable Upper Intake Level (35mg)
  • 42% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

This formula combines plant sterols and niacin, which have moderate to strong evidence for supporting healthy cholesterol levels. Chromium and garlic are included for their potential roles in metabolic and cardiovascular health, though evidence for some components is more limited. The profile maintains a high safety score with minimal reported concerns.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 66.67mg is 1.9× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for Cholesta-Lo
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Tablet(s)
Serving Size
Other Combinations
Product Type
42%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

66.67 mg (333% DV)
Exceeds UL by 1.9× (UL: 35 mg) 196 studies (A:5, B:63)
33.34 mcg (28% DV)
Within RDA (1.0× RDA) 199 studies (A:1, B:55)
Cholestatin Plant Sterols
200 mg
Market median: 500.0mg (497 products) 135 studies (A:0, B:40)
Parsley
83.33 mg
Chickweed
83.33 mg
66.67 mg
Market median: 250.0mg (337 products) 127 studies (A:1, B:41)
Cayenne
66.67 mg
50 mg
Market median: 333.0mg (166 products) 9 studies (A:0, B:2)
Eleuthro root extract
25 mg
Polygonum cuspidatum root extract
6.67 mg
Bronson BioAccelerators
7.67 mg

Other Ingredients

Maltodextrin Cellulose Croscarmellose Sodium Stearic Acid Silica Crospovidone Magnesium Stearate Talc Aqueous Tablet Coating
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

DIRECTIONS: As a dietary supplement for adults, take 3 tablets daily or as directed by a healthcare professional.

Warnings & Precautions

WARNING: If you are pregnant, nursing, taking any medications or planning any medical procedure, consult your doctor before use.

Discontinue use and consult your doctor if any adverse reactions occur.

Keep out of reach of children.

Formulation Notes

Contains soy.

Additional Information

Made in USA

No. 905A REF 0610

SUPPORTS HEALTHY CHOLESTEROL LEVELS

Store in a cool, dry place. Protect from light.

Metadata

Product Details

UPC / SKU7 16563 90501 9
DSLD Entry Date2012-04-26
Product TypeOther Combinations
FormTablet or Pill
BrandBronson
DSLD ID8228
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

Rezistaf
LifeLink · Tablet or Pill
100
Coenzymated B-3 25 mg
Source Naturals · Tablet or Pill
100
Vitamin B Complex
Simply Supplements · Tablet or Pill
100
Test X180 Boost
Force Factor · Tablet or Pill
100
8-Hour Alert
MHP Maximum Human Performance · Tablet or Pill
100
View all Niacin products →
Niacin research Best Niacin All Niacin products More from Bronson View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.